These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25130409)

  • 21. Clinical translation of recommendations from randomized clinical trials on patching regimen for amblyopia.
    Jin YP; Chow AH; Colpa L; Wong AM
    Ophthalmology; 2013 Apr; 120(4):657-62. PubMed ID: 23395531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia.
    Holmes JM; Edwards AR; Beck RW; Arnold RW; Johnson DA; Klimek DL; Kraker RT; Lee KA; Lyon DW; Nosel ER; Repka MX; Sala NA; Silbert DI; Tamkins S;
    J AAPOS; 2005 Apr; 9(2):129-36. PubMed ID: 15838439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occlusion treatment for amblyopia: assessing the performance of the electronic occlusion dose monitor.
    Fronius M; Chopovska Y; Nolden J; Loudon SE; Lüchtenberg M; Zubcov A; Pepler L
    Strabismus; 2006 Jun; 14(2):65-70. PubMed ID: 16760110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of visual acuity in a historical cohort of 137 patients treated for amblyopia by occlusion 30-35 years ago].
    Simonsz-Tóth B; Loudon SE; van Kempen-du Saar H; van de Graaf ES; Groenewoud JH; Simonsz HJ
    Klin Monbl Augenheilkd; 2007 Jan; 224(1):40-6. PubMed ID: 17260318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levodopa-carbidopa with occlusion in older children with amblyopia.
    Bhartiya P; Sharma P; Biswas NR; Tandon R; Khokhar SK
    J AAPOS; 2002 Dec; 6(6):368-72. PubMed ID: 12506278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of occlusion treatment in amblyopia and clinical risk factors affecting the results of treatment.
    Arikan G; Yaman A; Berk AT
    Strabismus; 2005 Jun; 13(2):63-9. PubMed ID: 16020359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A special role for binocular visual input during development and as a component of occlusion therapy for treatment of amblyopia.
    Mitchell DE
    Restor Neurol Neurosci; 2008; 26(4-5):425-34. PubMed ID: 18997317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Part-time vs. full-time occlusion for amblyopia: evidence for part-time patching.
    Matta NS; Silbert DI
    Am Orthopt J; 2013; 63():14-8. PubMed ID: 24260802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS).
    Stewart CE; Moseley MJ; Stephens DA; Fielder AR
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3048-54. PubMed ID: 15326120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of occlusion therapy on motion perception deficits in amblyopia.
    Giaschi D; Chapman C; Meier K; Narasimhan S; Regan D
    Vision Res; 2015 Sep; 114():122-34. PubMed ID: 26049038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children.
    Holmes JM; Kraker RT; Beck RW; Birch EE; Cotter SA; Everett DF; Hertle RW; Quinn GE; Repka MX; Scheiman MM; Wallace DK;
    Ophthalmology; 2003 Nov; 110(11):2075-87. PubMed ID: 14597512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recovery of contour integration in relation to LogMAR visual acuity during treatment of amblyopia in children.
    Chandna A; Gonzalez-Martin JA; Norcia AM
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4016-22. PubMed ID: 15505051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of amblyopia therapy initiated after 9 years of age.
    Park KH; Hwang JM; Ahn JK
    Eye (Lond); 2004 Jun; 18(6):571-4. PubMed ID: 15184922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anisometropic amblyopia treated with spectacle correction alone: possible factors predicting success and time to start patching.
    Chen PL; Chen JT; Tai MC; Fu JJ; Chang CC; Lu DW
    Am J Ophthalmol; 2007 Jan; 143(1):54-60. PubMed ID: 17113556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Amblyopia Using Personalized Dosing Strategies: Statistical Modelling and Clinical Implementation.
    Wallace MP; Stewart CE; Moseley MJ; Stephens DA; Fielder AR;
    Strabismus; 2016 Dec; 24(4):161-168. PubMed ID: 27929726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatial-frequency-dependent changes in cortical activation before and after patching in amblyopic children.
    Weiss AH; Kelly JP
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3531-7. PubMed ID: 15452059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blue filter amblyopia treatment protocol for strabismic amblyopia: a prospective comparative study of 50 cases.
    Metzler U; Ham O; Flores V; Claramunt M; Sepulveda C; Casanova D
    Binocul Vis Strabismus Q; 1998; 13(4):241-8. PubMed ID: 9852438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between stereopsis and visual acuity after occlusion therapy for amblyopia.
    Lee SY; Isenberg SJ
    Ophthalmology; 2003 Nov; 110(11):2088-92. PubMed ID: 14597513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of 3 hours part-time occlusion treatment combined with near activities among children with unilateral amblyopia.
    Alotaibi AG; Fawazi SM; Alenazy BR; Abu-Amero KK
    Saudi Med J; 2012 Apr; 33(4):395-8. PubMed ID: 22485234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychosocial and clinical determinants of compliance with occlusion therapy for amblyopic children.
    Searle A; Norman P; Harrad R; Vedhara K
    Eye (Lond); 2002 Mar; 16(2):150-5. PubMed ID: 11988815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.